B. James Tananbaum
Affiliations
- Large Shareholder, Director at Alumis Inc. (ALMS), 2025-05-07
- at Kinnate Biopharma Inc. (KNTE), 2024-04-05
- President And Ceo at Pardes Biosciences Inc. (PRDS), 2023-08-31
- Large Shareholder at Theseus Pharmaceuticals Inc. (THRX), 2023-07-19
- Large Shareholder at Aclaris Therapeutics Inc. (ACRS), 2021-11-03
- Large Shareholder, Director at Gemini Therapeutics Inc. (GMTX), 2021-10-06
- Director at Quantum-Si Inc (QSI), 2021-06-14
- Large Shareholder at 10X Genomics Inc. (TXG), 2020-05-14
- Large Shareholder at Aerie Pharmaceuticals Inc (AERI), 2020-03-02
- Large Shareholder at Aimmune Therapeutics Inc. (AIMT), 2016-08-19
- Large Shareholder at Intellia Therapeutics Inc. (NTLA), 2016-05-05
- Large Shareholder at Ambit Biosciences Corp (AMBI), 2013-10-16
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| ALMS | $4.34 | 20,000 | $86,800.00 | 4,247,670 | 2025-05-06 | Filing |
| ALMS | $4.62 | 25,000 | $115,500.00 | 4,227,670 | 2025-05-02 | Filing |
| ALMS | $16.00 | 2,187,500 | $35,000,000.00 | 4,202,670 | 2024-07-01 | Filing |
| ALMS | $16.00 | 312,500 | $5,000,000.00 | 5,584,889 | 2024-07-01 | Filing |
| KNTE | $2.80 | 229,044 | $641,323.20 | 520,711 | 2023-05-08 | Filing |